© 2009 American Public Health Association DOI: 10.2105/AJPH.2009.161281
Brian J. Morris is with the School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, Australia. Stefan A. Bailis is with the Research & Education Association on Circumcision Health Effects, Bloomington, MN. Jake H. Waskett is with the Circumcision Independent Reference and Commentary Service, Manchester, England. Thomas E. Wiswell is with the Disney Children's Hospital, Orlando, FL. Daniel T. Halperin is with the Harvard School of Public Health, Boston, MA. Correspondence: Requests for reprints should be sent to Professor Brian J. Morris, School of Medical Sciences and Bosch Institute, Building F13, The University of Sydney, Sydney, New South Wales 2006, Australia (e-mail: brianm@medsci.usyd.edu.au).
We applaud Leibowitz et al. for describing the adverse impact on public health of the withdrawal by 16 states of Medicaid coverage for male circumcision.1 However, we are alarmed by a subsequent letter by anticircumcision lobbyists, in which the evidence regarding circumcision is thoroughly misrepresented.2
Their claims flatly contradict the bulk of the legitimate medical literature demonstrating that male circumcision protects against urinary tract infections, HIV, HSV-2, syphilis, chancroid, thrush, bacterial accumulation, human papillomavirus, penile (and possibly prostate) cancer, local inflammation (balanitis), phimosis, paraphimosis, sexual problems with age, and, in female partners, human papillomavirus, cervical cancer, HSV-2, chlamydia, and bacterial
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||